Name: CMV Screening and Prevention
Uploaded: 2022-07-21T21:21:24.887Z
Description: Thought leaders discuss the low rates of screening for CMV and what healthcare providers can do to boost prevention efforts.

Breast Health

COVID-19

Cervical Health 

Contraception

Curbside Consults

Dermatology

Drug Pipeline News

Endometriosis

Genetic Testing

Gynecologic Oncology

Gynecology

Fetal Imaging

Abnormal Obstetrical Ultrasound

Ultrasound

Women's Imaging

Breast Imaging

Women's Ultrasound

Imaging

Infertility

LARC

Legally Speaking

Life Transitions

Malpractice

Menopause

Mental Health

Noninvasive Prenatal Testing

Obstetrics

Opinion

Osteoporosis

Pediatrics

Practice Management

Pregnancy and Birth

Sexual Health

Sexually Transmitted Infections

Surgery

Technology

Urology

Uterine Fibroids

Vulvovaginal Disease

Well Woman

About

News

Media

Podcasts

Insights

Medical World News

Peer Exchange

Peers & Perspectives

Videos

Conferences

Conference Coverage

Conference Listing

Publications

Contemporary OB/GYN® Journal

Digital Supplements

CME/CE

Resources

Physician Fact Sheets

Interactive Tools

Supplements and Featured Publications

Subscribe

Editorial Board

Partnerships

Articles

Discover how maternal vascular indices at 35 to 37 weeks' gestation offer crucial predictive value for identifying preeclampsia risk.

Study finds maternal vascular indices predict preeclampsia at 36 weeks

A recent suggests that implementing a personalized opioid prescription protocol significantly reduces total morphine milligram equivalents and the number of opioid tablets prescribed at discharge following cesarean delivery.

Personalized opioid protocol for cesarean deliveries: Reduced prescriptions reported

A recent study revealed that women who experience major adverse pregnancy outcomes face heightened long-term mortality risks, shedding light on the need for comprehensive understanding and preventative measures in women's health.

Long-term mortality risks for women with adverse pregnancy outcomes

A recent meta-analysis suggests sex as a modifying factor in the development of ABCA4-associated retinopathy, revealing a higher proportion of women among individuals with a mild reduced penetrant ABCA4 variant, impacting prognosis predictions and recurrence risks.

Gender discrepancy found in ABCA4-associated retinopathy

Advertise

Contact Us

Job Board

Terms of Use

Privacy Policy

Do Not Sell My Personal Information

Contemporary OB/GYN

Twitter

Facebook

LinkedIn

RSS Feed

Spotlight

CMV: In the Know

RSV Roundtable

STIs

Supplement: Closing the Gap in Cervical Cancer Screening

Vaginismus: Managing a Misunderstood and Underdiagnosed Condition

Why vNOTES Make Sense for My Patients

1rem

View

In this educational roundtable, a multidisciplinary panel of experts explores symptoms and risk factors of CMV and highlights the unmet needs around screening and prevention.

Allison August, MD, Kathleen Muldoon, PhD, Stanley Plotkin, MD, and Patricia Purcell, MD, MPH, share recommendations for messaging that healthcare providers should be sharing regarding CMV.

Overview and Prevalence of CMV

Signs, Symptoms, and Risk Factors for CMV

Allison August, MD, Kathleen Muldoon, PhD, Stanley Plotkin, MD, and Patricia Purcell, MD, MPH, explore key strategies and takeaways that healthcare providers can use to discuss transmission of CMV with their patients.

CMV Transmission

Thought leaders discuss the low rates of screening for CMV and what healthcare providers can do to boost prevention efforts.

CMV Screening and Prevention

Allison August, MD, Kathleen Muldoon, PhD, Stanley Plotkin, MD, and Patricia Purcell, MD, MPH, reveal tips regarding the most important points to emphasize when talking to patients about CMV.

The Importance of the HCP-patient CMV Conversation

Experts discuss the trajectory of CMV awareness and vaccine development efforts.

Historical Difficulty in Safely and Effectively Preventing CMV

CMV Screening and Prevention

EP: 1.Overview and Prevalence of CMV

EP: 2.Signs, Symptoms, and Risk Factors for CMV

EP: 3.CMV Transmission

EP: 4.CMV Screening and Prevention

EP: 5.The Importance of the HCP-patient CMV Conversation

EP: 6.Historical Difficulty in Safely and Effectively Preventing CMV